Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, were looking for a way to tackle diabetes, which the wife suffered from.

Novo Nordisk CEO Lars Fruergaard Jorgensen has ... justifying the company’s drug pricing – prices that Senator Bernie Sanders has slammed as “outrageously high.” Sanders accused the ...

Sen. Bernie Sanders questions Novo Nordisk CEO Lars Jorgensen in a hearing on Capitol Hill about the high prices Americans pay for Ozempic and Wegovy compared with people in other countries.

US Senator Bernie Sanders has pointedly asked why Novo Nordisk is charging Americans “10 or 15 times more for the same exact product than you’re charging people in Canada and Europe.

During the hearing, U.S. Senator Bernie Sanders accused Novo Nordisk, the drug company producing Ozempic and Wegovy, of overcharging Americans for the medications used to treat diabetes and obesity.

Jorgensen’s decision was revealed in a statement from Senator Bernie Sanders (I-Vt), who had threatened to subpoena the company to force Novo Nordisk’s North America operations chief ...

U.S. Senator Bernie Sanders intensified pressure on Novo Nordisk (NVO) to lower the prices of its popular diabetes and weight-loss drugs, Ozempic and Wegovy, during a Senate hearing. Sanders ...

After decades as a political outsider, Sanders has used his committee chairmanships and proximity to the White House to ...

President Biden and Sen. Bernie Sanders (I-Vt.) will travel to New Hampshire on Tuesday to speak on health care savings ...

(CNN) — While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, on Tuesday, Sen. Bernie Sanders alleged that 40,000 ...

Today Senator Bernie Sanders and his powerful Senate HELP Committee spent two hours questioning the CEO of Novo Nordisk about the drugs' prices. NPR pharmaceuticals correspondent Sydney Lupkin is ...